Signals, Powered By EquityPandit
The German drug regulator has issued six major observations to Dr Reddy’s Laboratories for its formulations manufacturing facility in Duvvada.
On behalf of European Union, the Regulatory Authority of Germany (Regierun von Oberbayern) has inspected the facility.
Dr Reddy’s said that the observations were “zero critical”.
The company has said that “Products manufacturing at the facilityare not currently exported to the EU.”
It further said that it will be submitting a Corrective and Prevention Action plan (CAPA) to the authorities.
